Please Note: This activity is no longer available for Credit.

Activity Title: PAH Today: Mastering Current, Tailored Treatment

Accreditation Type: AMA PRA Category 1 Credit(s)™

Release Date: 4/30/18

Expiration Date: 4/29/19

Estimated Time to Complete Activity: 1 hour, 45 minutes

LEARNING OBJECTIVES

Upon completion of the activity, participants should be able to:

• Summarize key efficacy and safety findings associated with recent studies on established and emerging therapy options for PAH
• Provide an evidence-based rationale to support selection of (a) particular treatment(s) or regimen(s)
• Discuss treatment approaches for clinical scenarios that can present special challenges to the clinician

FACULTY

James R. Klinger, MD

Professor of Medicine
Alpert Medical School Brown University
Division of Pulmonary, Sleep and Critical Care Medicine
Rhode Island Hospital

Robert P. Frantz, MD
Department of Cardiovascular Medicine
Mayo Clinic 

METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT

1. There are no fees for participating in and receiving credit for this activity. 
2. Review the activity objectives and CME/CE information.
3. Complete the CME/CE activity 
4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
5. Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
6. Credit documentation/reporting:
   • If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download.

ACCREDITED PROVIDER
This activity is provided by The France Foundation.

TARGET AUDIENCE

This educational initiative is intended for pulmonologists, cardiologists, internists, nurses and other healthcare providers involved in the management of patients with PAH.

ACCREDITATION STATEMENT 

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

Physicians: The France Foundation designates this enduring activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME accredited provider. 

DISCLOSURE POLICY

In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures 

The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Faculty Disclosures

The following faculty report that they have relevant financial relationships to disclose: 

• James R. Klinger, MD, has done research for Actelion, Bayer, Elger, Liquidia, Lung International and United Therapeutics. 
• Robert P. Frantz, MD, has served as a consultant, advisory board member, and steering committee member for Actelion Pharmaceuticals US, Inc., Arena Pharmaceuticals, Inc., St. Jude Medical, Bayer Pharmaceuticals, and United Therapeutics Corporation. He has received institutional grant or research support from Actelion Pharmaceuticals US, Inc., United Therapeutics Corporation, Gilead Sciences, Inc., and the National Institutes of Health.

DISCLOSURE OF UNLABELED USE

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information. 

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., and Bayer HealthCare Pharmaceuticals, Inc.

DISCLAIMER 

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter assume no liability for the information herein.

COPYRIGHT INFORMATION
Copyright © 2018 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions: 

• The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered. 

• Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without The France Foundation's prior written permission. 

PRIVACY POLICY
The France Foundation protects the privacy of personal and other information regarding participants and educational collaborators. The France Foundation will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The France Foundation maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse or alteration of information that we have collected from you.

Additional information regarding The France Foundation’s Privacy Policy can be viewed at http://www.francefoundation.com/privacy.

CONTACT INFORMATION

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.